Single Dose, Randomized, Two-period, Two-treatment, Two-sequence Crossover Relative Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets Under Fasting Condition.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2011
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Acute sinusitis; Bacterial infections; Intestinal infections; Intra-abdominal infections; Nosocomial pneumonia; Pyelonephritis; Respiratory tract infections; Skin and soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- 15 Jun 2011 New trial record